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Various post-translational modifications (PTMs) fine-tune the functions of almost all eukaryotic
proteins, and co-regulation of different types of PTMs has been shown within and between a number
of proteins. Aiming at a more global view of the interplay between PTM types, we collected
modifications for 13 frequent PTM types in 8 eukaryotes, compared their speed of evolution and
developed a method for measuring PTM co-evolution within proteins based on the co-occurrence of
sites across eukaryotes. As many sites are still to be discovered, this is a considerable underestimate,
yet, assuming that most co-evolving PTMs are functionally associated, we found that PTM types are
vastly interconnected, forming a global network that comprise in human alone 450 000 residues in
about 6000 proteins. We predict substantial PTM type interplay in secreted and membraneassociated proteins and in the context of particular protein domains and short-linear motifs. The
global network of co-evolving PTM types implies a complex and intertwined post-translational
regulation landscape that is likely to regulate multiple functional states of many if not all eukaryotic
proteins.
Molecular Systems Biology 8: 599; published online 17 July 2012; doi:10.1038/msb.2012.31
Subject Categories: metabolic and regulatory networks; signal transduction
Keywords: post-translational modifications; protein regulation; proteomics; PTM code; PTM crosstalk

Introduction
After translation, protein function is mainly regulated by the
tight interplay between protein–protein interactions and posttranslational modifications (PTMs) (Seet et al, 2006). As many
as 435 different PTM types are listed in the Uniprot database
(The UniProt Consortium, 2010). They affect a significant
fraction of eukaryotic proteins (Cohen, 2000; Weinert et al,
2011) and can interplay within or between these, either
regulating different activities or mediating functional associations among modified residues of the same or different PTM
types (Yang, 2005; van Noort et al, 2012). This PTM coregulation has been shown to be crucial for the control of
several important cellular processes (Kontaki and Talianidis,
2010). The examples of histone tail modifications (Latham and
Dent, 2007) and p53 regulation (Brooks and Gu, 2003) have
been used to suggest that most eukaryotic proteins may be
subjected to PTM co-regulation to fine-tune their functional
roles and a general ‘PTM code’ was postulated (Benayoun and
Veitia, 2009). The conservation status of the respective sites,
i.e., the modified amino acids, has been used as a proxy to
measure PTM activity (Boekhorst et al, 2008), their location
within protein structure (Landry et al, 2009), amino-acid
specificity (Chen et al, 2010) or distribution in the quaternary
& 2012 EMBO and Macmillan Publishers Limited

structure (Jensen et al, 2006). Both conservation of modifications and PTM co-regulation are key features to understand
protein regulation and their impact on the global protein
interaction network of a cell.
Several studies reported on the conservation of individual
PTM types (Boekhorst et al, 2008; Tan et al, 2009; Kumar and
Balaji, 2011) and recently two PTM types have been
comparatively analyzed (Weinert et al, 2011). However, to
understand global PTM co-regulation, their evolution and the
mechanistic insights that help deciphering the PTM code, a
consistent framework has to be developed that allows the
integration of many PTMs in a systematic manner.
Indeed, most mechanistic studies of protein modifications
are still based on single PTMs (Choudhary et al, 2009;
Oppermann et al, 2009; Zielinska et al, 2010) and are
performed on individual or small groups of proteins (Brooks
and Gu, 2003; Latham and Dent, 2007). Only recently, largescale analyses revealed crosstalk of two types of PTMs which
compete for the same residue (Danielsen et al, 2011), but many
other ways of PTM functional associations are conceivable
(Hunter, 2007). Also, in-silico perturbations of acetylation sites
(Lu et al, 2011) has been used to measure structural changes in
other PTM types.
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We collected a large data set of experimentally verified
sites for 13 abundant PTM types in 8 eukaryotes to (i)
compare the speed of evolution of the different PTM types by
means of a novel algorithm that takes into account the
phylogenetic relationships among the species with the
conserved amino acid, and (ii) to investigate, using information theory, the co-evolution of the modified residues as a
proxy for their functional association. Focusing on PTM coevolution within proteins, we identified a total of 35 pairs of
different PTM types that are likely to interplay (450% of all
pairs analyzed), consisting of 474 000 modified residues,
suggesting a global network of functionally associated PTM
types. Our predictions cover well-known types of PTM
crosstalk, but also hint at many new functional associations,
in particular in secreted and membrane-associated proteins.
Moreover, we derive functional context for many cases of
PTM type interplay by identifying domains in which the
functional association preferably occurs and by detecting
linear sequence motifs that appear to be linked to specific
pairs of PTM types.

Results
A non-redundant compendium of PTM sites
in eukaryotes
We compiled 4420 000 experimentally verified PTMs of 89
different types from public data sets from a total of 2485 species.
After a preprocessing step to remove sequence redundancies, a
total of 115149 distinct modified residues of 13 types from 8
eukaryotic species from human to yeast were used for further
analysis (Figure 1; for details see Materials and methods and
Supplementary Dataset 1). The by far most abundant modification type in the data set is phosphorylation with almost 93 000
sites followed by N-linked glycosylation with 8827 sites
(Figure 1A). C-linked glycosylation with only 45 collected sites
was used as cutoff as with fewer sites the statistics do not allow
to significantly reveal co-evolution (see Materials and methods
and Supplementary Figure 1). The respective residues were
found in a total of 21046 proteins, 17 562 of them are
phosphorylated implying a mean of 5.3 reported phosphorylation sites per protein, followed by acetylation of 3432 proteins
(2.2 sites per protein), while C-linked glycosylation is the least
frequent modification type in the data set covering only 12
proteins (3.8 sites per protein). Most PTM types show a
preference for a particular cellular location, functionality and
protein region (Supplementary Figure 2).
Proteins in our data set are not only modified by several
PTMs of the same type but frequently also by multiple types.
Each protein contains on average a total of 4.5 modified
residues from the 13 PTM types studied and 20.8% of the
proteins in our data set contain two or more modification types
(Figure 1B). While proteins have in general less PTMs than
expected (if the total PTMs in the data set are randomly
assigned to the same number of proteins), a few of them have
far more PTMs than the random expectation, which suggest
that many sites are still to be discovered (Supplementary
Figure 3). Thus, as it is also unlikely that we retrieved all PTM
sites that have been experimentally verified, the PTM density
used here has to be considered as a vast underestimate (Cohen,
2 Molecular Systems Biology 2012

2000). The highly abundant phosphorylated and glycosylated
(O- or N-linked) residues are found in combination with all
other PTM types (Figure 1C). The majority of observed PTM
co-occurrences within proteins do not compete for the same
type of amino acid (Wang et al, 2010; Danielsen et al, 2011)
implying mostly other mechanisms of functional association.
Comparing the distribution of the number of PTM types over
proteins to the random expectation (PTMs in data set
randomly assigned to the same number of proteins), we found
that proteins have less PTM types than expected, which again
suggest the incompleteness of the data set (Supplementary
Figure 3).

Differing conservation of PTM types within
eukaryotes
We comparatively studied the conservation status of the 13
PTM types as the first step for understanding their functional
relations and their co-occurrence within proteins. As experimental data are not yet covering all organisms comprehensively, we assume, as implemented in other algorithms for
similar purposes (Chica et al, 2008; Malik et al, 2008; Biswas
et al, 2010), that the conservation of the site can be a good
approximation for the conservation of the PTM. Indeed, this
approach has been used to distinguish between functional and
non-functional phosphorylation sites (Gnad et al, 2007; Holt
et al, 2009; Tan and Bader 2012) and a less-strict criterion, the
overall conservation of the proteins, was applied to determine
the age of the PTMs functionality (Choudhary et al, 2009;
Zielinska et al, 2010).
Thus, we aligned orthologs from 55 completely sequenced
eukaryotic genomes taken from the eggNOG resource (Muller
et al, 2010b) to the proteins with experimentally validated sites
(for details see Supplementary Figure 4 and Materials and
methods) and used multiple alignments to develop a Residue
Conservation Score (RCS). RCS is composed of two elements
(Figure 2A): (i) the evolutionary spread of species that contain
a conserved residues, captured by the maximum branch length
(MBL) of any two species containing the same residue as the
PTM site and (ii) the conservation within the taxonomic range
determined by the common ancestor of all species containing
the conserved sites, expressed as Residue Conservation Ratio
(RCR), see Materials and methods. By multiplying MBL and
RCR, we take into account highly conserved PTMs that are
only found in a narrow taxonomic range (e.g., primates) and
taxonomically widespread PTMs (like phosphorylation) that
are less conserved. For algorithm performance tests see
Supplementary Figures 5 and 6. As different proteins have
varying rates of evolution (Huerta-Cepas et al, 2007), we
normalize every PTM RCS value using RCSs of non-modified
amino acids identical to the one in the PTM site across all
orthologs in the alignment, whereby we distinguish between
ordered and disordered regions and calculates the relative RCS
(rRCS; see Materials and methods, Supplementary Figure 4
and Supplementary Dataset 2 for details).
As expected, ordered protein regions are generally significantly more conserved than disordered regions in our data set
(Supplementary Table 1). However, a separate comparison
of the global distribution of RCSs for modified versus
& 2012 EMBO and Macmillan Publishers Limited
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Figure 1 Statistics of the PTMs in the data set. (A) Number of residues and proteins per PTM type, PTM types are abbreviated as Ph (phosphorylation), NG (N-linked
glycosylation), Ac (acetylation), OG (O-linked glycosylation), Ub (ubiquitination), Me (methylation), SM (SUMOylation), Hy (hydroxylation), Ca (carboxylation), Pa
(palmitoylation), Su (sulfation), Ni (nitrosylation) and CG (C-linked glycosylation). (B) Breakdown of modified proteins by the number of PTM types per protein; the
proteins with the highest PTM type frequency have all been intensively studied, e.g., coagulation factors, hypoxia-inducible factor or p53. (C) Co-occurrence of different
types of PTMs within proteins, nodes size represent the abundance of proteins with a particular PTM type, the edge widths represent the number of proteins modified by
the two respective PTM types normalized by the total number of proteins with the less abundant PTM type. Phosphorylated and glycosylated (O- or N-linked) residues
are found in combination with all other PTM types followed by acetylation which it is not present together with C-linked glycosylation and carboxylation; only carboxylation
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non-modified residues in both ordered and disordered regions
reveals significantly more site conservation of all PTM types
compared with background residues (Supplementary Figure 7
and Supplementary Table 2).
For example, if we choose a rRCS of 95 as a stringent cutoff to
evaluate the conservation of a residue, meaning that the
modified residue is more conserved than 95% of the nonmodified residues, we find that 17.7% of the experimentally
determined human phosphosites of serine are significantly
conserved (16.5% for serine, threonine and tyrosine together).
Using the same threshold, acetylations and N-linked glycosylations have higher rates of conservation, 26 and 20%,
respectively. When comparing the 8 eukaryotes studied,
human and mouse had very similar conservation levels while
yeast sites appeared less conserved (Supplementary Table 3).
When comparing the different PTM types to each other
using our scoring scheme (Figure 2B), carboxylation clearly
stands out as the most conserved while SUMOylation is the
fastest evolving PTM. Analysis of independent data sets
derived from different species reveals that larger data sets
(like human and mouse) show the best concordance while
smaller ones contain more variability (Figure 2C), yet
supporting the notion of similar roles of PTMs in different
& 2012 EMBO and Macmillan Publishers Limited

eukaryotic species (for more details see Supplementary
Figures 8 and 9).

Co-evolution of sites within proteins reveals a
global network of functionally associated PTM
types
With the conservation status of the PTMs in hand, we were
able to analyze the co-evolution of pairs of modified residues
as a proxy of their functional association. The predicted
functional associations (or the synonym ‘interplay’) are
broadly defined here, ranging from physical interactions or
competition for a site to co-regulation or involvement in at
PTM signaling cascade. We use the loosely defined, but
frequently used term crosstalk only in reference to published
work.
We focus here on the co-occurrences of any two sites within
a protein as the statistical framework is straightforward in
contrast to co-occurrences in different proteins. We used
mutual information (MI), corrected to exclude anti-correlation
of residues, to measure the co-occurrence of two sites to
identify pairwise co-evolution (Figure 3A). We evaluate the
Molecular Systems Biology 2012 3
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Figure 2 Differential conservation of PTM types. (A) The RCS is composed of two components: the MBL that is the longest evolutionary distance among species that
contain a conserved modified residue and the RCR that quantifies the conservation ratio of the modified residue across the species in a taxonomic group in which a least
one conserved site residue has been observed. The score is illustrated by a modified serine (circled) within a column of a MSA of orthologs where the species with the
longest branch length containing the residue are Macaca mulatta and Rattus norvergicus; In the respective taxonomic group, 3 out of 4 species maintain the serine in the
same position and thus the RCR is 0.75. (B) Average of the relative RCS (rRCS, obtained via comparison of RCSs of other residues in the protein, see Materials and
methods for details) per each PTM type in human and in all species together. (C) Distribution of the mean of the rRCS in each PTM type across 8 eukaryotes. Colors
indicate the degree of conservation (blue for more conserved residues and red for fastest evolving ones). PTM types are sorted according to the human values.

significance of the co-occurrence of two sites in the phylogeny
of species encoding the orthologous groups (OGs) by permuting the species labels 100 times and then comparing the MI of
the modified sites with the MI they would obtain in all possible
tree scenarios (see Materials and methods and Supplementary
Figure 10). MI has already been successfully used for
analogous problems in molecular biology, such as the
identification of interdependent mutations, protein interactions or protein residues co-evolution (Korber et al, 1993;
Huynen, 2000; Martin et al, 2005) among others, and pinpoints
here concrete pairs of PTM residues that are likely to be
functionally associated within proteins.
A systematic analysis of the co-evolution of each pair of PTM
sites within each protein of our data set (excluding those
modifications that target the same residue) revealed that
74 386 residues in 10 325 proteins are co-evolving (Supplementary Dataset 3), i.e., predicted to be functionally associated, and this is only counting the pairs of PTMs for which
the sites have been experimentally verified; the numbers
increase 420-fold if one considers all orthologs in which the
sites are conserved (1 683187 sites in total). While 251 211
functional associations are predicted between residues of the
same PTM type, 47 993 reveal co-evolution between different
PTM types. All together, we find significant global co-evolution
in 35 pairs of different PTM types while 12 PTM types (all
except C-linked glycosylation) show also global co-evolution
with themselves (links not shown). This implies a global
network of predicted functional links among PTM types
(Figure 3B) that involves in human alone 51 844 sites of 6013
proteins whereby many PTMs still have to be discovered
implying considerably more intertwining of PTM types. This
4 Molecular Systems Biology 2012

extensive interplay is in particular striking for some PTM types
for which only few sites are known, suggesting that they must
contain a high degree of co-evolution to be detectable with
statistical significance (see details for robustness of the
network in Supplementary Figure 11A).
All types of modifications but C-linked glycosylation, for
which we have the fewest experimentally verified sites, are
predicted to functionally associate on average with six other
PTM types whereby competition of different PTM types for the
same residues is not even considered here (see Materials and
methods) and we only record co-evolution within the same
protein. Phosphorylation, for which by far the most sites are
known, globally associates with 11 other PTM types, closely
followed by both major types of glycosylations as well as
acetylation, which all are also PTMs with many known sites.
Phosphorylation, N-linked glycosylation and carboxylation
are found to have the highest fraction of co-evolution within a
PTM type and differ from the other modifications in that they
have more predicted functional associations within the PTM
type than between PTM types (Supplementary Figure 11B and
C). Although the total amount of co-evolution correlates with
the abundance of known sites, some PTM types seem to be
more often functionally associated than others: 82.4% of Oglycosylated proteins have at least one link while the
corresponding fraction for phosphorylation is only 56.4%
(Figure 3B). Of all the proteins with a recorded PTM, 37%
contain at least one site that functionally associate with
another PTM type, and another 61% contain associations
between PTMs of the same type.
Pairs of detected co-evolving residues were significantly
more conserved than random pairs of modified residues
& 2012 EMBO and Macmillan Publishers Limited
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(P-value o2.2 e  16; see Materials and methods) highlighting
an underlying functional role and supporting the predictive
potential of our approach. We next explored the functions to
which each type of co-evolving PTM pair could contribute.
When we compared the sets of proteins subjected to each of
the co-evolving pairs of PTM types to sets of proteins subjected
to the same type of PTMs which are not co-evolving, 43 out of
the 47 pairs of PTM types found significantly co-evolving (35
between different PTM types and 12 self associations) were
found to be enriched in particular functions or cellular
components in the context of the Gene Ontology (Ashburner
et al, 2000; Supplementary Datasets 4 and 5). In respect to
known protein–protein interaction networks that they are part
of, 23 out of the 47 pairs have a higher degree of connectivity
than sets of random proteins and 10 out of these 23 if we
compare against sets of proteins with the same PTM types
which are not co-evolving (see Supplementary Figure 12 and
Materials and methods for details).
To gain more functional insight into proteins with coevolving PTMs, we extracted the preferred functionalities
(more general functions than those defined by GO terms) that
are annotated in the different pairs of PTM type interplay (see
Materials and methods and Supplementary Figure 13). While
some pairs of co-evolving PTM types target proteins that are
involved in a broad spectrum of functions (eight of these pairs
target proteins involved in more than four different general
functions), other pairs of co-evolving PTM types are quite
specific, i.e., 15 of them target proteins involved in a single
function. Nuclear processes such as chromatin structure and
dynamics, RNA processing and transcription are enriched in
proteins with predicted functional associations between
mainly phosphorylation, acetylation, methylation, SUMOylation and ubiquitination. However, each of the pairs have their
own particularities, which again suggests the presence of a
global PTM code that could be elucidated only with detailed
mechanistic knowledge about each of these processes. We
observe also that certain PTM types are linked to very different
functionalities depending on which other PTM type they are
co-evolving with. For instance, proteins that harbor coevolving O-linked glycosylation and N-linked glycosylation
sites appear to be involved in processes related to extracellular
structures and signal transduction, while proteins harboring
co-evolving O-linked glycosylation and ubiquitination,
SUMOylation or methylation are linked very specifically to
transcription. The latter can be still functionally separated at a
more fine-grained resolution: e.g., proteins harboring coevolving O-linked glycosylation and SUMOylation sites are
specifically involved in cell differentiation and tissue
development.
To assess the novelty within the delineated global network
of functionally associated PTM types, we extracted Medline
abstracts with co-occurring names of modifications
(Supplementary Table 4) and reviewed the resulting large
corpus manually (see Supplementary Materials for details on
this revision). We then classified the pairs of PTM types as
being (i) generally known (although we vastly extend the
number of individual incidences), (ii) proposed (based on an
individual protein or an individual case study so that almost all
of our individual predictions can be considered novel) and (iii)
undescribed. A total of 12 known PTM type crosstalks are well
6 Molecular Systems Biology 2012

established in the literature and we see all of them in our
network (Figure 3B). Furthermore, we generalize in 9 of 12
proposed PTM type crosstalks from individual observations or
proposals to large number of instances. Finally, we identified
14 previously undescribed pairs of functionally associated
PTM types for which to the best of our knowledge interplay has
not been reported yet (solely red lines in Figure 3B).
As the network of functionally associated PTM types is
strikingly enriched in membrane-associated or secreted
proteins, we also systematically recorded the preferred cellular
localization of the proteins in which we find co-evolution
(Figure 3C). PTM type interplay appears to be enriched in
proteins that can be classified according to the following
preferred localizations: (i) In the nucleus or cytoplasm PTM
interplay is found, e.g., in the histone regulation or wellstudied crosstalk between phosphorylation, acetylation and
ubiquitination occurs in a number of cytoplasmic processes
such as protein degradation. (ii) In membrane-associated and
secreted proteins where we found a considerable amount of
unexpected functional associations. In human alone, 34
proteins that are at least partially secreted contain co-evolving
and thus predicted functionally associated phosphorylations
and N-linked glycosylations. Phosphorylation, associated with
intracellular processes, was also found to be heavily coevolving with palmitoylation and sulfation, two other modifications that occur exclusively in secreted proteins. As
phosphorylation cannot actively happen outside the cells, it
is likely that the interplay takes place in the endoplasmic
reticulum in the context of decorating proteins with complex
PTM structures before export. In total, 17 out of the 35 pairs of
different PTM types with significant co-evolution levels occur
mostly in secreted or membrane-associated proteins, implying
that PTM interplay is crucial for the regulation of the protein
export process. Finally, there is also PTM type interplay (iii) in
proteins with a broad localization spectrum, which stand for
example for functional interactions between phosphorylation,
acetylation, ubiquitination and O-glycosylation.

Functional implications of co-evolving PTM types
With the large data set of co-evolving PTMs in hand, we tried
to explore some of the mechanisms underlying the complex
network of functionally associated PTMs shown in Figure 3B
and C. We followed three different approaches: First, we
analyzed the pairs of co-evolving PTMs for their proximity in
sequence and structure to get an indication whether they could
be physically interacting. It has previously been shown that
some PTMs and PTM types can form clusters of sites that act as
regulatory centers, e.g., the highly modified cassette of amino
acids in p53 (Brooks and Gu, 2003). To generalize such
physical interactions to all PTM types, we performed a nonparametric comparison of the distances between the modified
residues in both sequence and structure (the former as a proxy
of real spatial separation) with equivalent modified but not coevolving residues from the same proteins. Our results indicate
that 25 out of the 35 PTM type pairs identified as co-evolving
have their residues closer in sequence or structure than
comparable modified but not co-evolving residues (see
significance levels at Figure 4A and B). Out of the PTM type
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pairs that do not significantly co-evolve more than expected,
we find five more pairs of PTM types with co-evolving residues
closer in sequence than non-co-evolving modified sites. Two of
these have some instances of crosstalk reported in the
literature supporting the notion that our network of functionally associated PTMs within protein is far from complete.
Nuclear and cytosolic PTM types such as those in proteasome
degradation seem to be frequently interacting physically as
they are found in close distance in sequence, in structure or in
both. Also, residues with co-evolving PTM types associated to
membrane-related or secreted proteins tend to be close in
space, for instance carboxylated and hydroxylated residues
known to co-regulate in coagulation factors and vitamin
k-dependent proteins (Castellino et al, 2008), or N-linked
glycosylated and acetylated sites which are found to be
significantly closer in both structure and sequence in 41
proteins but their association is not reported in the literature
(see Supplementary Material for a review on known and novel
associations between PTM types).
In a second approach, we aimed to place PTM type coevolution into a functional context via their preferred locations
in protein domains. We performed an enrichment analysis to
identify PTM types that are more likely located within a
specific domain when they are co-evolving with a particular
PTM type in comparison to their presence in isolation or their
co-evolution with any other PTM type. A total of 31 Interpro
domains were identified this way, 8 of them were already
reported to be regulated by the functional association we
predicted, 13 were described to be regulated by both PTM
types independently, for 9 only one of the two PTM types had
been associated with the domains and for one domain we did
not find any literature connection to any of the two PTM types
(Supplementary Table 5). An example in which the association
of a domain with one PTM type has been previously shown but
where we can add both mechanistic detail and generalization
are spectrin repeats. Proteins containing co-evolved phosphorylation and acetylation sites are more often phosphorylated
inside spectrin repeats than proteins that are either only
phosphorylated or functionally associated to any other
modification. Phosphorylation is known already to regulate
several functions in which spectrin repeats play a role such as
neuritogenesis (Bignone et al, 2007) or the stability of the
erythrocytes membrane (Perrotta et al, 2001). Due to the
enrichment and detection of the crosstalk in a number of
spectrin repeats, e.g., in F-actin cross-linking proteins (Actn1,
Actn4), Dystrophin (Dmd) and microtubule-actin cross-linking factor 1 (Macf1), we can hypothesize that the interplay
between acetylation and phosphorylation in conjunction with
the spectrin repeat might be a more general mechanistic
scenario for the coordinated regulation of conditional binding
of large cytoskeletal macromolecules and perhaps even for the
formation of cytoskeletal networks. The prediction of mechanistic details is illustrated by Actn4 in which the acetylated
residues have been identified by a global screen without
mechanistic context (Choudhary et al, 2009): given the
spectrin repeat enrichment, we hypothesize that it is their
interplay with phosphorylation that fine-tunes the spectrin
functionality (Figure 4C).
In a second example, we were able to infer a known
regulatory process from the linkage of two different pairs of
& 2012 EMBO and Macmillan Publishers Limited

co-evolving PTM types to the same globular domain. It
confirms our predictions and suggests particular residues to
be involved that so far have not been related to the process. In
the RelA subunit of the transcription factor NF-k-B, we found
an association of the cell surface receptor domain (IPT/TIG)
with pairs of co-evolving phosphorylated and acetylated
residues as well as with co-evolving phosphorylated and
methylated residues. The activation of NF-k-B via the
regulation of its subunit RelA seems to be mediated by a
series of crosstalk events between different modifications: e.g.,
acetylation has been found to inhibit methylation and to
enhance ubiquitination that leads to protein degradation, thus
methylation appears as a stabilizer that permits its DNAbinding activity (Yang et al, 2010). In addition to this regulation,
phosphorylation of serine 276, which is inside the IPT/TIG
domain, enhances the RelA acetylation (Chen et al, 2005) and
phosphorylation also inhibits methylation (Levy et al, 2011). In
our predictions, we found not only the reported S276 coevolving with methylated and acetylated residues but also with
three more phosphorylated sites inside the domain (S205, S281,
T254). Those phosphosites would be co-regulating the protein
localization together with a number of acetylated and
methylated residues (Figure 4D). Our results suggest that the
massive phosphorylation of the IPT/TIG domain would force
RelA to degrade probably by means of enhancing a multiacetylation (K122, K123, K218, K221, K310, K314, K315) and
inhibiting methylation (Figure 4D). More examples of domain
associated to co-evolving pairs of PTM types can be found in
Supplementary Table 5. The domain approach illustrated here
by the two examples thus provides mechanistic hypotheses and
pinpoints to particular residues that are involved.
A third way to gain mechanistic insights is based on the
occurrence of common short (3–10 residues long) linear motifs
that are often found in unstructured regions. Proteins with a
common interaction partner, or a family of interactors, can be
enriched in such short-linear motifs that facilitate the binding
(Sudol, 1998; Neduva et al, 2005). Using Gibbs sampling
(Davey et al, 2010), we identified short-linear motifs for every
group of proteins with a pair of co-evolving PTM types (see
Materials and methods, Supplementary Table 6). We found 24
linear motifs, which can be merged into 12 clusters based on
their sequence composition, that are enriched in proteins
harboring 8 pairs of co-evolving PTM types; one of the motifs
is shared by two different pairs of interplaying PTM types (so
13 relations in total). Based on a database similarity search
(see Materials and methods) and a literature survey, we
consider 4 out of the 12 motifs identified this way as being
novel. In all, 7 of the 8 known motifs had been identified in the
context of PTMs, so that we see our approach as confirmatory,
although in each of these cases we also add novel aspects. As
many as five motifs have been already associated to both PTM
types individually but had never been connected to an
interplay, two more motifs have been found to be associated
to only one of the two co-evolving PTM types for which an
enrichment was found and the last two known motifs have not
been connected yet to PTMs (for details and references see
Supplementary Table 6). For example, the known linear motif
DLF (Asp–Leu–Phe) was found to be enriched in 19 proteins
containing co-evolving methylated and phosphorylated residues. The DLF motif had previously been implicated in the
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processes such as DNA replication, repair (Dalrymple et al,
2001) and vesicle trafficking (Mills et al, 2003) and we
identified additional proteins from these processes harboring
functionally associated methylated and phosphorylated residues. Furthermore, at least 6 of the 19 proteins in this data set,
including PABPC1 (Figure 4E), are involved in RNA processing, identified by a functional enrichment analysis (see

binding of CEBPB to the Rb–E2F complex, which is involved in
cell-cycle regulation and synthesis of DNA (Darnell et al, 2003)
although no PTMs were studied to regulate this process. We
found a DLF motif in the methylated–phosphorylated protein
P53bp1 which also interacts with the Rb–E2F complex (Mani
et al, 2008) suggesting a similar, hitherto unknown regulation
mechanism. DLF has also been associated to other cellular
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Materials and methods), suggesting a novel functionality
for the motif associated to co-regulated methylation and
phosphorylation residues.
An example of how protein localization can be regulated by
PTM interplay is the functional association between acetylated
and SUMOylated residues within the nuclear localization
signal (NLS), a short-linear motif (K-K/R-X-K/R) that triggers
the signaling cascade leading to the nuclear translocation of
proteins upon recognition by importins (Lange et al, 2007). We
found this motif in 35 proteins harboring co-evolving
acetylated and SUMOylated residues. A connection between
phosphorylation and acetylation as such has already been
described: While acetylation of NLS serves as a signal for
nuclear import (Spilianakis et al, 2000), phosphorylation is a
signal for cytoplasmic retention (Harrison et al, 2010).
SUMOylation has also been reported as a signal to initiate
the transport to the nucleus, e.g., for the Daxx protein
(Chen et al, 2006); while other proteins first need the NLS
signaling for their transport and are SUMOylated afterwards
(Rodriguez et al, 2001). From the set of proteins with the (K-K/
R-X-K/R) motif we found both mechanisms of regulation. On
one hand, the protein Poly (A) polymerase a (PAPOLA) is
SUMOylated at two of the lysines of the NLS motif (KKTK) that
are co-evolving with several acetylated residues. SUMOylation
of PAPOLA is required for its transport to the nucleus
(Vethantham et al, 2008) while acetylation would change its
role to inhibit the translocation (Shimazu et al, 2007),
Figure 4F. In contrast, histone deacetylase 1 (HDAC1) has
two acetylated lysines inside the NLS motif (KKAKR) that are
co-evolving with two SUMOylated residues, suggesting that
SUMOylation probably takes place in the nucleus after the
protein transport (Figure 4G). More examples on associations
of co-evolving PTM types to short-linear motifs can be found at
Supplementary Table 6.

Discussion
Despite increasing efforts in large-scale discovery of individual
PTM types, they are still an understudied source of cellular
complexity (Deribe et al, 2010). Patterns of residues that are
modified by different PTM types change during the life time of
a protein, whereby little is known mechanistically about their
interplay and dynamics in most cellular processes.
Here, we present the first large-scale study that comparatively analyses several PTM types in different eukaryotes,
estimate their conservation in a consistent framework and

derive a global network of functionally associated PTM types
based on co-evolution of modified residues within proteins.
Given the incompleteness of data and the inherited underestimate of co-regulated sites (residues that do not co-occur
might also be functionally associated given the fast evolution
of some sites, so conservation is only one of the features that
can be used to detect associations) we expect that the
incidences of PTM interplay, each enriched in proteins with
particular functionalities, will vastly expand in the future and
should provide sufficient information to eventually decipher
the proposed PTM code in a global way by adding more
detailed information about the mechanistic nature of the
functional associations.
The global network of functionally associated PTM types
revealed already spatio-temporal specificities of PTM interplay
(Figure 3C). Central to the PTM network appear phosphorylation, acetylation, ubiquitination and O-linked glycosylation
that control both temporal events (e.g., transcriptional
regulation) and processes that govern protein localization
(e.g., export or membrane-association). These modifications
seem widespread insight the cell and are amended by others
with more restricted localization in secreted proteins or the
nucleus. Although details of their predicted functional
associations still need to be carved out, the tendency for
close proximity in sequence and structure indicates a tendency
for physical interactions of co-evolving PTMs in particular
pairs of PTM types. Moreover, as we restricted our analysis
to eukaryotes but prokaryotes harbor also a number of
PTM types, it remains to be seen how far back in evolution
this fundamental principle of protein regulation can be
traced.
Most of the domains and motifs we found to be linked to
functionally associated PTM types were already connected to
individual PTMs or to a regulation of protein interactions; the
role of PTM type interplay in these appears new as the
regulation of protein binding has only been reported for
individual PTMs (Neduva et al, 2005; Seet et al, 2006). Many
more such links are likely due to the incompleteness of the
data set. Our analysis provides first insights into the vast
amount of interdependencies of different PTM types in the
formation of distinct functional states of proteins from all
cellular processes. It is likely that this global network also
extends to PTM interplay between proteins, e.g., within
protein complexes as already demonstrated at a small scale
(Shukla et al, 2009). Furthermore, as we only analyzed
pairwise interactions, examples of local, physically linked

Figure 4 Properties and functional implications of functionally associated PTMs. Residues of several co-evolving PTM types are found to be close in sequence (A) or
structure (B) compared with equivalent modified, but not co-evolving residues in the same proteins. All PTM types pairs shown in (A, B) have co-evolving sites
significantly closer than control sets with an adjusted P-value by FDR o0.05 in some of the 100 repetitions the analysis was repeated as we work with random sets as
background. The bootstrapping values for the number of times the difference was found significant is showed by * (450 times) and ** (100 times). The PTM types pairs
are classified according to their status in our prediction, in black the pairs that we predict to be functionally associated, in red the ones that did not show a global coevolution and in blue the pairs found to be associated only in the literature, in this two last cases even if a global co-evolution was not significant, several residues were
found to be significantly co-occurring. For more distance analysis see Supplementary Figure 14. (C) Co-evolving PTM types are associated to protein domains probably
regulating their activity, illustrated by phosphorylated and acetylated residues in the spectrin repeats of the protein ACTN4, spectrin repeats are in general enriched in the
association between these two PTM types. (D) Protein RelA is phosphorylated inside the cell surface receptor domain in four residues (S205, T254, S276 and S281) that
are found co-evolving with both, methylated and acetylated residues. As suggested by the reported co-regulation between phosphosite S256 and acetylated and
methylated residues, a more general scenario is proposed where four phosphorylation would be enhancing the acetylation of seven lysines that would lead to protein
degradation. In the absence of phosphorylation, four residues would become methylated and the protein translocated to the nucleus. (E) The DLF motif is associated with
the co-evolution of phosphorylations and methylations, illustrated by the example of the PABPC1 protein. (F, G) Co-evolving methylated and SUMOylated residues can
regulate protein localization in different ways depending on which type of modification is placed inside the nuclear localization signal (NLS) motif.
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networks of PTMs (Figure 4C–G) illustrate that those local
PTM networks within proteins will increase the number of
functional states in a combinatorial way. Linking these to
protein interaction networks would imply a complexity that
would affect each cell types in different ways and allows finetuning of the regulation of all cellular processes.

Materials and methods
Data collection, annotation and sequence
redundancy reduction
We compiled all PTMs available at UniProt (The UniProt Consortium,
2010), dbPTM (Lee et al, 2006), PHOSIDA (Gnad et al, 2010),
PhosphoSite (Hornbeck et al, 2004), HPRD (Keshava Prasad et al,
2009), OglycBase (Gupta et al, 1999) and PhosphoELM (Dinkel et al,
2010). UniProt predictions labeled as inferred ‘by similarity’ or
‘potential’ were not included in the data set, nor in the analysis. For
each modification, we recorded the protein id, type of modification,
organism, amino acid and sequence position.
After collection, performed id and OG mapping and retrieved the
protein sequences. We performed a pre-processing task to discard
sequences that are identical or overlapping (e.g., peptides into protein
sequences). The STRING database v8.3 (Jensen et al, 2009) is used for
the id mapping and sequence retrieval. Sequences with no exact match
to the corresponding sequence in the OG were excluded from the
analysis. From the resulting number of PTMs and species present in
the filtered data set, we selected only those sets, PTM types and
organisms, with enough data to perform an accurate statistical
analysis (see next point).
The selected proteins were annotated to their cellular locations
according to Uniprot cellular component keywords ontology. The
protein function was inferred from their OGs (Tatusov et al, 1997) as
provided by the eggNOG database (Muller et al, 2010b).

Selection of PTM types to include in the analysis
In the collection of PTMs we found a large set of PTM types with only a
few residues annotated in the databases. To assess the lower limit of
the number of residues that a PTM type should have to be able to be
detected significantly co-evolving with any other PTM type, we
performed a simulation to test the capacity of our statistical framework
to detect global co-evolution between two PTM types.
We first calculated the average ratio of modified residues versus nonmodified residues (background) measured in all comparisons (0.13)
and the average ratio of pairs of residues with significant co-evolution
versus the pairs not found co-evolving for both sets: modified residues
and non-modifies residues (1.53 and 0.45, respectively). Using these
proportions we simulated the results (number of co-evolving residues
versus not co-evolving residues in modified and non-modified
residues) that are the input for the Fisher test that calculates whether
a pair of PTM types is globally co-evolving compared with comparable
non-modified residues. This type of analysis was performed for 50
simulated PTM types (each of them increases its number of residues in
one, from 1 to 50 residues). We introduced two variables in these
simulations: (i) the number of residues with other PTM type that are
present in the same protein of at least one residue of the simulated PTM
type (overlapping residues), we performed simulations for 1 to 8
overlapping residues and (ii) the number of not co-evolving modified
residues of the simulated PTM type (from 0 to the number of residues
overlapping).
Per each of the rounds of simulations (50 simulated PTM types with
x number of overlapping residues and y number of not co-evolving
residues), we generated the input for the Fisher test and added to the
pipeline that gets adjusted P-values (by false discovery rate (FDR))
including all the results for the comparisons of the larger PTM types
(13 in total) to simulate a real scenario in the adjustment of the
P-values. See results in Supplementary Figure 1.
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Evaluation of the number of PTMs and unique PTM
types per protein
We built the expected distributions of the number of proteins with a
particular number of PTMs and PTM types by randomly assigning the
modifications we have in our data set to the proteins in each of the
species in the study. We used the non-parametric Kolmogorov–
Smirnov test to compare the expected distributions with the distributions extracted from our data set. We used Fisher exact test to evaluate
whether the number of proteins with more than one PTM type in our
data set is more than expected. See results in Supplementary Figure 3.

Functional enrichment analysis of protein with
a specific PTM type
We analyzed the enrichment of protein functions and cellular location
as well as type of protein region where the modified residues are
located (i.e., ordered or disordered regions) for each set of proteins
with a particular PTM type. The functional classifications for the
proteins were obtained from metazoa OGs (meNOGs) from the
eggNOG database, as a consensus between coverage and wealth of
annotation. The reference set for the functional enrichment was the
whole set meNOG functional classification. As mentioned before, we
used Uniprot annotation for deriving protein location. We used the
whole set of proteins from Uniprot from the 8 selected species from
which we study the PTMs as the reference set for the location
enrichment analysis. We also annotated the protein regions (ordered
or disordered regions) where the modifications are placed and
performed an enrichment analysis of any of these two categories in
the global distribution of ordered and disordered region of the proteins
belonging to the species under study. The DisEMBL algorithm v.1.4
(Linding et al, 2003) was used for the detection of disordered regions
within proteins using COIL definition for the disordered regions.
For all the comparisons, we applied a Fisher exact test with P-values
adjusted by FDR for the whole set of tests. Adjusted P-values below
0.05 were taken as significant.

Species tree
We built a phylogenetic species tree based on the NCBI taxonomy,
which is known to be accurate for most taxa (Benson et al, 2010; Sayers
et al, 2011), and inferred branch lengths. To assess the branch lengths,
we generated alignments of 40 ubiquitous, single copy marker genes
(Ciccarelli et al, 2006) for 853 different species using AQUA (Muller
et al, 2010a) and combined the tree topology of the NCBI taxonomy tree
with them using PhyML (Guindon et al, 2010). The resulting tree was
manually curated and genomes that had an erroneous placement in the
NCBI taxonomy tree were removed. The final tree includes 851 taxa
including 35 eukaryotes, 43 archaea and 773 bacteria. Of the
eukaryotic taxa included in the tree, 17 were metazoan (8 mammalia;
3 primates) and 13 were fungi.

Mapping proteins to OGs and tree generation
pipeline
The database eggNOG v2.0 was used to map every protein in the data
set to the oldest eukaryotic OG in which the protein is present and
generated a multiple sequence alignment (MSA) and sequence tree
using PhyML v.3.30. TreeKO (Marcet-Houben and Gabaldón, 2011)
algorithm was used to root the tree and decompose the sequence tree
into a set of all possible pruned trees with no duplications and in
consonance with the species tree topology. The set of pruned trees
includes all combinations of splitting the duplication events so that
there are no trees with paralogous sequences but at least one tree for
each paralog. The branch lengths for this tree are derived from the
species tree. For all trees in this set that include the reference sequence,
the residue RCS (see next section) is calculated for the modified
residue. The tree in which the modified amino acid presents a higher
score is selected for the evaluation.
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RCS calculation
The RCS for amino acid aa (RCSaa) evaluates the conservation of a
particular amino acid (aa) within its position in the MSA of the
corresponding OG. As explained in previous section, the resulting tree
generated from the OG has been reconciled and has branch lengths
information based on the species tree. The RCSaa is composed by two
components, the RCR, which represents the occurrence of the amino
acid in the exact position in the sequences present in the pruned tree
generated from the MSA and the MBL, which is the maximum branch
distance between any pair of the species represented in the tree with
the modified residue present in the aligned position.
To avoid that the size of the OG affects RCS, we get the oldest
common ancestor of any two pairs of sequences with the amino acid
conserved and only the descendants of this common ancestor are
taking in consideration for the calculation. Thus, RCSaa ¼ RCRMBL
aa
and Naa is the number of times aa appears in
where RCSaa ¼ TotalNSequences
that position.

Reference distribution calculation for the
normalization of the RCS
As the overall conservation status of the protein can indeed be a bias
for the measurement of the conservation of the modified site, we
generated a specific reference distribution of conservation of nonmodified residues for every modification in the data set in order to
normalize its RCS. To build the reference distribution for a particular
modified site, we calculate the RCS for all non-modified residues from
the OG that are of the same type of amino acid as the one with the PTM
and it is placed in the same class of protein region (ordered or
disordered). The RCS of the modified site is then mapped into the
reference distribution to calculate the percentile of its value, this
percentile is what we name relative RCS (rRCS). Only those
modifications with 410 values in the reference distribution were
selected for the conservation analysis.

Comparison of conservation distributions
We used the non-parametric Kolmogorov–Smirnov test to calculate the
statistical significance of two distributions of RCSs or rRCSs.
In order to obtain a ranking of the overall conservation status of PTM
types and function/location specific sets of PTMs, we calculate the
mean of all rRCSs for every of these sets.

Extraction of co-evolving PTM pairs
We used the MI algorithm (Cover and Thomas, 1991) to evaluate the
co-evolution of two PTMs in the same protein. The MI of two variables
yÞ
(Y, X) is measured as MIðX; YÞ ¼ x2X y2Y pðx; yÞ log P1pðx;
ðxÞP2 ðyÞ where
p (x, y) is the joint probability of X and Y, and p1(x) and p2(y) are the
probabilities of X and Y, respectively. As MI measures the dependency
of two variables, the PTM pairs modifying exactly the same residue
within the protein were excluded from the analysis. We also excluded
proteins which OG have o7 species and modified sites who are not
conserved in at least 4 species and at most in the total number of
species in the OG minus 3. MI values representing anti-correlation
were converted to negative values to allow this measurement to
distinguish between cases were co-evolution is real (common cooccurrences of sites in the same species) and cases were the presence
of the site in the species set is complementary (high MI value but low
co-evolution), see Figure 3A.
In every protein we built a set of different PTM pairs with all the
modified residues present in the sequence. In order to avoid the effect
of the possible co-evolution of PTMs of the same type increasing the
global co-evolution measurement of a pair of PTMs due to multiple
cross-evaluation, for a pair of PTM types, we only allow a particular
modified residue to be present in a single pair of PTMs, the selection is
done randomly. We then calculate the MI for the set of pairs selected
and per each MI calculated we permute the species labels of one of the
two residues 100 times and calculate again its MI. The permutations
generate a reference distribution where the MI can be mapped in with a
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non-parametric approach. If the percentile of the modified residue is
above 95 we assume the residues are co-evolving to a significant
degree. The same approach is applied to a set of random pairs of nonmodified residues selected under same conditions, same amino acids
and same protein region distributions.
To evaluate the global co-evolution of two types of PTMs (as well as
self co-evolution), we performed a Fisher exact test to see whether the
ratio of the modified residues above 95 percentile on their reference
distributions is significantly higher than the same ratio in nonmodified residues. As the selection of the random pairs of residues can
affect the result of the Fisher test, we repeated the whole process 100
times. P-values were corrected for FDR and value o0.05 taken as
significant. The number of times we found that a pair of PTM types is
significantly associated (maximum 100 and minimum 1) is then used
to evaluate the coverage of the co-evolving pairs of PTMs within the
whole set of pairs with the same type of PTMs.

Comparison of conservation between co-evolving
and non-co-evolving modified residues
We compared by a Fisher exact test the number of times the rRCS of the
modified and co-evolving residues is greater and lower than 95%
against the same parameters for the modified but no co-evolving
residues.

Preferred functionality for a set of proteins
To extract the preferred functions of the set of proteins with at least one
pair of co-evolving modified residues, we used the annotation
provided by the proteins OGs in the metazoa level (meNOGs) from
the eggNOG database. A functionality is classified as preferred when
the number of proteins annotated with such term is above the number
of proteins annotated to any of the cellular locations present in the set
as expected by chance plus 10 percent.

Preferred cellular location for a set of proteins
To extract the preferred location of the set of proteins with at least one
pair of co-evolving modified residues, we used the cellular component
annotation extracted from Uniprot (see above). A cellular location is
classified as preferred when the number of proteins annotated with
such term is above the number of proteins annotated to any of the
cellular locations present in the set as expected by chance plus 10
percent.

Gene Ontology enrichment analysis
We performed a Gene Ontology terms enrichment analysis to every set
of proteins with a particular pair of co-evolving PTM types using the
FatiGO (Al-Shahrour et al, 2004) software available at the Babelomics
suite (Medina et al, 2010). We first filtered the sets of proteins with coevolving pairs of PTM types to include only human proteins (by far the
most abundant in the data set). We did the same filtering to proteins
sets with the same type of modifications but found not co-evolving and
we used them as respective background lists. We evaluated the
enrichment of Gene Ontology terms in biological processes, molecular
function and cellular component categories restricted to a propagated
annotation in level 5 (as a good compromise between the detail and the
amount of the annotation retrieved) and using a two-tailed Fisher exact
test for the enrichment analysis. P-values are adjusted by FDR and
significant values are taken as o0.05.

Enrichment analysis in protein–protein interaction
networks
We used the software SNOW (Minguez et al, 2009) available at
Babelomics suite (Medina et al, 2010) to evaluate the topological
parameters of the protein–protein interaction networks formed by the
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set of proteins with a particular type of co-evolving pair of PTM types.
As in the GO enrichment analysis previously described, we filtered the
proteins sets to include only human proteins. We generated two types
of background so the analysis was performed twice (all results shown),
first as in GO enrichment analysis we generated the set of human
proteins with same type of modifications but not co-evolving and the
second type of background was offered by the SNOW software as a set
of 500 random sets of proteins (with the same number of proteins as
the query set). The minimal connection network (MCN) in both
comparisons was generated allowing a single external protein to link
proteins in the set and taking protein–protein interactions from the
curated set SNOW provides. P-values are adjusted by FDR and
significant values are taken as o0.05.

Analysis of the proximity of the co-evolving PTMs
We measured the distance between PTM sites as the number of
intervening residues and in the available protein structures, in
Ångströms, of every pair of co-evolving amino acids for each pair of
PTM types. To have a reference distribution for each pair of PTMs, we
randomly selected the same number of amino acids with the same
PTM types, but found not co-evolving, from the same proteins and
measure their distance in the same way. Both, the distribution of
distances in the modified residues and the reference are then compared
applying Kolmogorov–Smirnov test. P-values are adjusted by FDR and
significant values are taken as o0.05. As the samples are small and the
random sets can alter the final results, we performed the analysis 100
times and at the end count the number of times the difference was
found significant.

Enrichment analysis of the interaction between
PTMs and protein domains
For every pair of PTM types with certain degree of co-evolution (red
lines at Figure 3B), we extracted the Interpro domains (Hunter et al,
2009) with one of the modifications inside. We used Interpro domains
instead of more curated databases, such as SMART (Letunic et al,
2012), to be able to include a wider definition of globular domains. We
also measured the number of times that a particular modification was
found inside the same domains when it is present in isolation or coevolved with any other PTM type. We performed an enrichment
analysis using Fisher exact test for each domain to test the difference
between these two ratios. P-values were adjusted by FDR for the whole
set of analysis and values o0.05 were taken as significant.

Extracting short-linear motifs enriched in sets of
proteins with co-evolving PTM pairs
We performed an enrichment analysis of short-linear motifs, of 3–10
residues, for every set of proteins with a particular pair of co-evolving
PTMs using the SliMFinder (Davey et al, 2010) software. Default
parameters were used for this analysis. The extracted linear motifs
were compared using CompariMotif (Davey et al, 2007) software to
known motifs belonging to all databases available in SlimFinder.

Identification of functions enriched in proteins
with co-evolving methylated and phosphorylated
residues and DLF motif
We performed a functional enrichment analysis with the proteins
having crosstalking methylated and phosphorylated residues and the
DLF short-linear motif using the FatiGO software (Al-Shahrour et al,
2004) available within the Babelomics suit of tools (Medina et al,
2010). We used Gene Ontology terms as protein annotation and chose
an adjusted (by FDR) P-value of 0.05 as the threshold for significance.
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